Syphilis Testing and Treatment
Diagnostic Testing
Syphilis diagnosis relies on serologic testing combined with clinical presentation consistent with active or latent infection. 1
- Nontreponemal tests (RPR or VDRL) should be used for initial screening and monitoring treatment response 2
- Treponemal tests confirm the diagnosis but correlate poorly with disease activity and should not be used to assess treatment response 2
- Do not switch between different nontreponemal test methods (e.g., RPR and VDRL) when monitoring serologic response, as results cannot be directly compared 2
- CSF examination is indicated for patients with neurological signs/symptoms, tertiary syphilis, ophthalmic disease, or those whose serologic titers fail to decline appropriately 2, 3
- HIV testing should be performed in all patients diagnosed with syphilis 4
- Dark field microscopy can confirm primary syphilis when mucocutaneous lesions are present 5
Treatment by Stage
Primary and Secondary Syphilis
Benzathine penicillin G 2.4 million units IM as a single dose is the definitive treatment for primary and secondary syphilis. 2, 3, 6
- This regimen has four decades of proven efficacy in achieving local cure, preventing sexual transmission, and preventing late sequelae 4
- For children: Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) as a single dose 4, 3
- Children should have CSF examination to exclude neurosyphilis and evaluation by child-protection services 4
Early Latent Syphilis
Benzathine penicillin G 2.4 million units IM as a single dose 2, 3
- Early latent syphilis is defined as infection acquired within the preceding year based on documented seroconversion, fourfold increase in titer, history of symptoms, or having a sex partner with documented early syphilis 2
Late Latent Syphilis and Tertiary Syphilis
Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at weekly intervals 2, 3, 6
- If a dose is missed, an interval of 10-14 days between doses may be acceptable before restarting the sequence 2
- Late latent syphilis is defined as infection of more than one year duration or unknown duration 6
Neurosyphilis
Aqueous crystalline penicillin G 18-24 million units daily, administered as 3-4 million units IV every 4 hours for 10-14 days 6
- High-dose IV penicillin G (above 10 million units) should be administered slowly due to potential electrolyte imbalance from potassium content 7, 8
- Penicillin G contains approximately 1.68 mEq potassium per million units 7
Alternative Treatments for Penicillin-Allergic Patients
Non-Pregnant Adults
For primary and secondary syphilis: Doxycycline 100 mg orally twice daily for 14 days 2, 3, 6
For late latent syphilis: Doxycycline 100 mg orally twice daily for 28 days 2, 3
- Tetracycline 500 mg orally four times daily is an alternative, though compliance is better with doxycycline due to less frequent dosing 6
- Ceftriaxone 1 g daily (IM or IV) for 8-10 days may be considered, though optimal dosing is not well established 6
- Azithromycin should not be used due to widespread macrolide resistance in T. pallidum in the United States 6
Pregnant Women and Neurosyphilis
Penicillin is the only proven effective therapy for preventing maternal transmission and treating neurosyphilis. 2, 3, 6
- Pregnant women with penicillin allergy must undergo desensitization and be treated with penicillin 2, 3, 6
- Alternative regimens are not adequately studied in pregnancy 6
Special Populations
HIV-Infected Patients
HIV-infected patients should receive the same penicillin regimens as non-HIV-infected patients 2, 3, 6
- HIV-infected patients may have atypical serologic responses but generally respond well to standard treatment 2
- More frequent monitoring is recommended: every 3 months rather than every 6 months 6
- Recent evidence suggests that single-dose BPG plus 7-day doxycycline achieves higher serologic response rates (79.5% vs 70.3%) compared to BPG alone in PWH 9
Pregnant Women
All pregnant patients should be screened for syphilis three times: at the first prenatal visit, during the third trimester, and at delivery 1
- Parenteral penicillin G is the only therapy with documented efficacy for preventing maternal transmission 2, 3
- Up to 40% of fetuses with in-utero exposure to syphilis are stillborn or die from infection during infancy 1
Follow-Up and Monitoring
Quantitative nontreponemal serologic tests should be repeated at 3,6,12, and 24 months after treatment 2, 3
- Expected serologic response: A fourfold decline in titer within 6 months for primary/secondary syphilis and within 12-24 months for late syphilis 2, 3
- Treatment failure is defined as: Failure of nontreponemal test titers to decline fourfold within 6 months after therapy for primary or secondary syphilis 2, 3
- If treatment failure is suspected, patients should be re-evaluated for HIV infection and undergo CSF examination 2
- Serologic tests may decline more slowly in patients who have had previous syphilis infections 6
Management of Sexual Partners
Persons exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should be treated presumptively, even if seronegative 4, 2, 3
- Persons exposed >90 days before diagnosis should be treated presumptively if serologic test results are not immediately available and follow-up is uncertain 4, 2
- Patients with syphilis of unknown duration and high nontreponemal titers (≥1:32) may be considered infected with early syphilis for partner notification purposes 4
- Long-term sex partners of patients with late syphilis should be evaluated clinically and serologically 4, 3
Time periods for identifying at-risk sex partners:
- Primary syphilis: 3 months plus duration of symptoms 4
- Secondary syphilis: 6 months plus duration of symptoms 4
- Early latent syphilis: 1 year 4
Important Clinical Considerations
Jarisch-Herxheimer Reaction
An acute febrile reaction may occur within 24 hours after any syphilis therapy, especially in early syphilis 2, 6
- Symptoms include fever, headache, myalgia, and other constitutional symptoms 2, 6
- Patients should be informed about this possible adverse reaction before treatment 2
Critical Pitfalls to Avoid
- Do not use oral penicillin preparations for syphilis treatment as they are ineffective 2
- Do not rely solely on treponemal test antibody titers to assess treatment response 2
- Avoid bacteriostatic antibiotics (chloramphenicol, erythromycins, sulfonamides, tetracyclines) concurrently with penicillin, as they may antagonize the bactericidal effect 7, 8
- Do not perform routine lumbar puncture for primary or secondary syphilis unless clinical signs or symptoms of neurologic or ophthalmic involvement are present 4
- Be aware that false-positive glucose reactions may occur with Benedict's solution, Fehling's solution, or Clinitest tablets after penicillin G treatment 7, 8
Prevention Strategies
Routine screening of sexually active people aged 15-44 years at least once, and at least annually for those at increased risk 1
- Men who have sex with men (MSM) comprised 32.7% of all males with primary and secondary syphilis in 2023 1
- Doxycycline postexposure prophylaxis: 200 mg doxycycline taken within 72 hours after sex is recommended for MSM and transgender women with a history of sexually transmitted infection in the past year 1
- Counseling about condom use should be provided 1